Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial
Year: 2008
Type: article
Source: Vaccine
Authors: Paul Spearman, Spyros Kalams, Marnie Elizaga, Barbara Metch, Ya-Lin Chiu, Mary Allen, Kent J. Weinhold, Guido Ferrari, Scott D. Parker, M. Juliana McElrath, Sharon E. Frey, Jonathan D. Fuchs, Michael C. Keefer, Michael D. Lubeck, Michael Egan, Ralph Braun, John H. Eldridge, Barton F. Haynes, Lawrence Corey
Institutions: Emory University, Vanderbilt University, Fred Hutch Cancer Center, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Duke University, University of Alabama, University of Alabama at Birmingham, UAB Medicine, Saint Louis University, San Francisco Department of Public Health, University of Rochester Medicine, University of Rochester
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W1972109233